A new strategy to identify hepatitis B virus entry inhibitors by AlphaScreen technology targeting the envelope-receptor interaction.

MLA

Saso, Wakana, et al. “A New Strategy to Identify Hepatitis B Virus Entry Inhibitors by AlphaScreen Technology Targeting the Envelope-Receptor Interaction.” Biochemical and Biophysical Research Communications, vol. 501, no. 2, June 2018, pp. 374–79. EBSCOhost, https://doi.org/10.1016/j.bbrc.2018.04.187.

APA

Saso, W., Tsukuda, S., Ohashi, H., Fukano, K., Morishita, R., Matsunaga, S., Ohki, M., Ryo, A., Park, S.-Y., Suzuki, R., Aizaki, H., Muramatsu, M., Sureau, C., Wakita, T., Matano, T., & Watashi, K. (2018). A new strategy to identify hepatitis B virus entry inhibitors by AlphaScreen technology targeting the envelope-receptor interaction. Biochemical and Biophysical Research Communications, 501(2), 374–379. https://doi.org/10.1016/j.bbrc.2018.04.187

Chicago

Saso, Wakana, Senko Tsukuda, Hirofumi Ohashi, Kento Fukano, Ryo Morishita, Satoko Matsunaga, Mio Ohki, et al. 2018. “A New Strategy to Identify Hepatitis B Virus Entry Inhibitors by AlphaScreen Technology Targeting the Envelope-Receptor Interaction.” Biochemical and Biophysical Research Communications 501 (2): 374–79. doi:10.1016/j.bbrc.2018.04.187.